Myconoes Wins £21k Innovate UK GrantGemma Cann2022-06-30T11:43:27+01:00February 2nd, 2022|BioCity Nottingham, News|
New Partnerships with Leading FirmsGemma Cann2023-09-04T12:43:33+01:00January 25th, 2022|Accelerator, News|
Pioneer Group Accelerator Winner AnnouncedGemma Cann2023-09-04T12:44:36+01:00January 21st, 2022|Accelerator, News|
Sygnature Discovery Appoints Dr Charles Woler as ChairmanGemma Cann2022-06-30T11:44:30+01:00January 14th, 2022|BioCity Nottingham, News|
NuVision Biotherapies Announces the Appointment of New CEO and COOGemma Cann2022-06-30T11:44:49+01:00January 14th, 2022|MediCity Nottingham, News|
Gateley Acquires IP Specialists Adamson JonesGemma Cann2022-06-30T11:45:01+01:00January 13th, 2022|BioCity Nottingham, News|
Oxomics’ New Blood-Based Test the First to Identify if a Patient has Cancer and if it has SpreadGemma Cann2023-09-04T12:46:40+01:00January 11th, 2022|News|
Novosound Enters Global Digital Health MarketGemma Cann2022-06-30T11:46:29+01:00January 5th, 2022|BioCity Glasgow, News|
Pioneer Group Accelerator Winner Announced: Pioneering Start-up Oxomics Receives £50KGemma Cann2023-09-04T12:48:30+01:00December 17th, 2021|Accelerator, News|
